Scott Cormack
2014
In 2014, Scott Cormack earned a total compensation of $1.7M as Former President and Chief Executive Officer at OncoGenex Pharmaceuticals, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,324 |
|---|---|
| Option Awards | $410,321 |
| Salary | $497,153 |
| Stock Awards | $655,320 |
| Total | $1,719,118 |
Cormack received $655.3K in stock awards, accounting for 38% of the total pay in 2014.
Cormack also received $156.3K in non-equity incentive plan, $410.3K in option awards and $497.2K in salary.
Rankings
In 2014, Scott Cormack's compensation ranked 5,163rd out of 13,032 executives tracked by ExecPay. In other words, Cormack earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,163 out of 13,032 | 60th |
Division Manufacturing | 1,842 out of 4,966 | 63rd |
Major group Chemicals And Allied Products | 611 out of 1,686 | 64th |
Industry group Drugs | 466 out of 1,365 | 66th |
Industry In Vitro and In Vivo Diagnostic Substances | 15 out of 72 | 79th |
Source: SEC filing on September 21, 2017.
Cormack's colleagues
We found two more compensation records of executives who worked with Scott Cormack at OncoGenex Pharmaceuticals in 2014.